𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor-β1 regulation of laminin γ1 and fibronectin expression and survival of mouse mesangial cells

✍ Scribed by Yan Jiang; Davis W. Cheng; Errol D. Crook; Lalit P. Singh

Publisher
Springer
Year
2005
Tongue
English
Weight
358 KB
Volume
278
Category
Article
ISSN
0300-8177

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of fibronectin and laminin re
Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor-β1
✍ Shuang Huang; Subhas Chakrabarty 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 638 KB

## Abstract Transforming growth factor (TGF)‐β~1~, modulates the expression of extracellular matrix (ECM) glycoproteins, fibronectin and laminin and the adhesion of Moser colon cancer cells to these glycoproteins. Since adhesion can be altered through expression of cell‐surface receptors, binding a

Transforming growth factor-β1 (TGF-β1) r
Transforming growth factor-β1 (TGF-β1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression
✍ Fei Han; Christopher S. Adams; Zhuliang Tao; Charlene J. Williams; Raihana Zaka; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB

## Abstract Regulated splicing of fibronectin (FN) occurs during the mesenchymal to chondrocyte transition and ultimately results in the relative enrichment of an extra domain B (EDB) exon‐containing FN isoform with the suggestion that FN isoforms may play a functional role in chondrogenesis. Promo

Altered expression of transforming growt
Altered expression of transforming growth factor-β1 mrna and protein in mouse skin carcinogenesis
✍ Benjamas Patamalai; David L. Burow; Irma Gimenez-Conti; Jean Claude Zenklusen; C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 894 KB

## Abstract Transforming growth factor (TGF)‐β1, whose gene is located on mouse chromosome 7, has been proposed to be involved in skin carcinogenesis. In the study presented here, we demonstrated that single topical treatments with different types of tumor promoters, i.e., the protein kinase C acti